YTE reported $181.74M in Net Income for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -14.46M 29.41M
Agios Pharmaceuticals AGIO:US $ -88.77M 2.55M
Alnylam Pharmaceuticals ALNY:US $ -204.51M 14.96M
Amgen AMGN:US $ 1884M 1420M
Biocryst Pharmaceuticals BCRX:US $ -58.8M 15.6M
Biogen BIIB:US $ 329.2M 119.3M
Biomarin Pharmaceutical BMRN:US $ -36.49M 49.44M
Bluebird Bio BLUE:US $ -216.82M 24.89M
Bristol Myers Squibb BMY:US $ 1546M 491M
Cerulean Pharma CERU:US $ -12.67M 3.5M
Chemocentryx CCXI:US $ -22.31M 16.9M
Clovis Oncology CLVS:US $ -67.41M 0.96M
Cti Biopharma CTIC:US $ -24.18M 4.5M
Eli Lilly And LLY:US $ 1110.1M 280.1M
Exelixis EXEL:US $ 38.2M 57.89M
Gilead Sciences GILD:US $ 2592M 1070M
Gw Pharmaceuticals GWPH:US $ -19.68M 9.47M
Idera Pharmaceuticals IDRA:US $ -5.96M 1.6M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
IONIS PHARMACEUT IONS:US $ -82M 1.12M
Macrogenics MGNX:US $ -52.89M 12.95M
Merk MRK:US $ 4567M 3022M
Mirati Therapeutics MRTX:US $ -80.05M 86.38M
Moderna Inc MRNA:US 3.33B 553M
Nektar Therapeutics NKTR:US $ -129.71M 4.19M
Neurocrine Biosciences NBIX:US $ 22.5M 19.8M
Newlink Genetics NLNK:US $ -7.49M 1.18M
Novartis NOVN:VX SF 2758M 138M
Novartis NVS:US $ 2758M 138M
Pfizer PFE:US $ 8146M 2582M
Ptc Therapeutics PTCT:US $ -133.62M 15.25M
Puma Biotechnology PBYI:US $ -44.67M 39.57M
Regeneron Pharmaceuticals REGN:US $ 1632.2M 1466.7M
Sarepta Therapeutics SRPT:US $ -48.14M 33.26M
Seattle Genetics SGEN:US $ -293.85M 209.27M
Ultragenyx Pharmaceutical RARE:US $ -73M 49.43M
Vertex Pharmaceuticals VRTX:US $ 851.93M 785M
YTE INCY:US $ 181.74M 32.28M